TrialMedicine2017

Hypouricemic and arthritis relapse-reducing effects of compound tufuling oral-liquid in intercritical and chronic gout: A double-blind, placebo-controlled, multicenter randomized trial.

Zhijun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.